2-tert-butylhydroquinone has been researched along with oxytocin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Freij, M; Kim, J; Phillippe, M; Saunders, T | 1 |
1 other study(ies) available for 2-tert-butylhydroquinone and oxytocin
Article | Year |
---|---|
Effects of 2,5-di(tert-butyl)-1,4-hydroquinone, an endoplasmic reticulum Ca(2+)-ATPase inhibitor, on agonist-stimulated phasic myometrial contractions.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium-Transporting ATPases; Dinoprost; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Female; Hydroquinones; Ionomycin; Myometrium; Oxytocin; Potassium Chloride; Rats; Rats, Sprague-Dawley; Uterine Contraction | 1995 |